Commonwealth Equity Services
ACOR

Commonwealth Equity Services’s Acorda Therapeutics ACOR Stock Holding History

Commonwealth Equity Services’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-130
Closed -$31K – 3000
2019
Q4 		$31K Buy
130
+25
+24% +$6.31K ﹤0.01% 2835
2019
Q3 		$36K Buy
+105
New +$57.1K ﹤0.01% 2763

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Commonwealth Equity Services's ACOR Position: Q1 2020 in Review

Commonwealth Equity Services sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 130 shares — an estimated $31K sold.

Commonwealth Equity Services first reported a position in ACOR in Q3 2019 and held it in 2 quarters. The position peaked at $36K in Q3 2019. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • Commonwealth Equity Services reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Commonwealth Equity Services sold 130 Acorda Therapeutics shares in Q1 2020, an estimated $31K.
  • Commonwealth Equity Services first reported a position in Acorda Therapeutics in Q3 2019 and held it in 2 quarters.
  • Commonwealth Equity Services's Acorda Therapeutics position peaked at $36K in Q3 2019.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on Commonwealth Equity Services's 13F filing for Q1 2020, filed 11 May 2020.